July

Children:

• Alzheimer’s Disease Risk Impacted by the Liver, Diet
• Aspirin Desensitization Improves Alcohol-Induced Allergies in Patients with Underlying Respiratory Disease
• Therapy for Rare Cancers Receives FDA Approval Following Trials at Penn’s Abramson Cancer
• Brain Stimulation Decreases Intent to Commit Physical, Sexual Assault
• Cancer Patients May Experience Delayed Skin Effects of Anti-PD-1 Therapy
• Chance of Being Prescribed Opioids for a Minor Injury Differs Dramatically by Where You Live
• Diabetes Drugs Act as Powerful Curb for Immune Cells in Controlling Disease-causing Inflammation
• Fat Production and Burning Are Synchronized in Livers of Mice with Obesity, Penn Study Finds
• Federal Government Approves Penn Medicine to Develop Imaging Guidelines
• Genome Editing Reduces Cholesterol in Large Animal Model, Laying the Groundwork for In-Human Trials
• Greening Vacant Lots Reduces Feelings of Depression in City Dwellers, Penn Study Finds
• Immunologist Named Chair of Systems Pharmacology
• Largest Genetic Database on Alzheimer’s Disease Now Re-open for Business
• News Release
• Nudging Doctors to Prescribe Cholesterol Lowering Statins Triples Prescription Rates
• Penn led Study Finds Mutation Driving Deadlier Brain Tumors and Potential Therapy to Stop It
• Penn Medicine Emergency Medicine Physician and Digital Health Care Innovator Raina Merchant, MD, Named Aspen Institute Health Innovator Fellow
• Penn Medicine Named Among Nation’s Best Employers for Women by Forbes
• Penn Medicine Pulmonologist and Medical Educator Jessica Dine MD Named Macy Faculty Scholar
• Penn Medicine’s Garret FitzGerald, Cardiovascular Disease and Translational Medicine Expert, Elected to Italian Science Academy
• Penn Medicine’s John Q. Trojanowski Receives Lifetime Achievement Award from Alzheimer’s Association
• Penn Wissahickon Hospice and Caring Way Earn the Circle of Life Award® from American Hospital Association for Innovative Palliative and End-of-Life Care
• Penn’s Brian Capell, MD, PhD, Wins Damon Runyon Clinical Investigator Award
• Red-Blood-Cell “Hitchhikers” Offer New Way to Transport Drugs to Specific Targets
• Rethinking Neurodegenerative Disease Treatment: Target Multiple Pathological Proteins, Not Just One
• Why Randomized Trials for Proton Therapy Are Difficult to Complete (And What We Can Do About It)